These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 17875736
1. 17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells. Pandini G, Genua M, Frasca F, Squatrito S, Vigneri R, Belfiore A. Cancer Res; 2007 Sep 15; 67(18):8932-41. PubMed ID: 17875736 [Abstract] [Full Text] [Related]
2. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M. Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214 [Abstract] [Full Text] [Related]
3. Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathway. Pandini G, Genua M, Frasca F, Vigneri R, Belfiore A. Ann N Y Acad Sci; 2009 Feb 01; 1155():263-7. PubMed ID: 19250214 [Abstract] [Full Text] [Related]
4. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT, Le H, McFann KK, Blackman MR. Am J Physiol Endocrinol Metab; 2005 Mar 01; 288(3):E573-84. PubMed ID: 15536203 [Abstract] [Full Text] [Related]
5. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B. J Endocrinol; 2005 Jun 01; 185(3):577-92. PubMed ID: 15930183 [Abstract] [Full Text] [Related]
6. Role of cyclic AMP response element-binding protein in insulin-like growth factor-i receptor up-regulation by sex steroids in prostate cancer cells. Genua M, Pandini G, Sisci D, Castoria G, Maggiolini M, Vigneri R, Belfiore A. Cancer Res; 2009 Sep 15; 69(18):7270-7. PubMed ID: 19738069 [Abstract] [Full Text] [Related]
7. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β. Rossi V, Bellastella G, De Rosa C, Abbondanza C, Visconti D, Maione L, Chieffi P, Della Ragione F, Prezioso D, De Bellis A, Bellastella A, Sinisi AA. J Cell Physiol; 2011 May 15; 226(5):1334-9. PubMed ID: 20945400 [Abstract] [Full Text] [Related]
8. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells. Pandini G, Mineo R, Frasca F, Roberts CT, Marcelli M, Vigneri R, Belfiore A. Cancer Res; 2005 Mar 01; 65(5):1849-57. PubMed ID: 15753383 [Abstract] [Full Text] [Related]
9. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Nickerson T, Chang F, Lorimer D, Smeekens SP, Sawyers CL, Pollak M. Cancer Res; 2001 Aug 15; 61(16):6276-80. PubMed ID: 11507082 [Abstract] [Full Text] [Related]
10. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. Migliaccio A, Di Domenico M, Castoria G, Nanayakkara M, Lombardi M, de Falco A, Bilancio A, Varricchio L, Ciociola A, Auricchio F. Cancer Res; 2005 Nov 15; 65(22):10585-93. PubMed ID: 16288052 [Abstract] [Full Text] [Related]
11. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. Maor S, Mayer D, Yarden RI, Lee AV, Sarfstein R, Werner H, Papa MZ. J Endocrinol; 2006 Dec 15; 191(3):605-12. PubMed ID: 17170218 [Abstract] [Full Text] [Related]
12. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D. Cancer Res; 2006 Apr 01; 66(7):3903-11. PubMed ID: 16585219 [Abstract] [Full Text] [Related]
13. Preferential expression of IGF-1Ec (MGF) transcript in cancerous tissues of human prostate: evidence for a novel and autonomous growth factor activity of MGF E peptide in human prostate cancer cells. Armakolas A, Philippou A, Panteleakou Z, Nezos A, Sourla A, Petraki C, Koutsilieris M. Prostate; 2010 Aug 01; 70(11):1233-42. PubMed ID: 20564425 [Abstract] [Full Text] [Related]
14. Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model. Krueckl SL, Sikes RA, Edlund NM, Bell RH, Hurtado-Coll A, Fazli L, Gleave ME, Cox ME. Cancer Res; 2004 Dec 01; 64(23):8620-9. PubMed ID: 15574769 [Abstract] [Full Text] [Related]
15. Regulation of interleukin-8 expression in human prostate cancer cells by insulin-like growth factor-I and inflammatory cytokines. Kooijman R, Himpe E, Potikanond S, Coppens A. Growth Horm IGF Res; 2007 Oct 01; 17(5):383-91. PubMed ID: 17513150 [Abstract] [Full Text] [Related]
17. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression. Grzmil M, Hemmerlein B, Thelen P, Schweyer S, Burfeind P. J Pathol; 2004 Jan 01; 202(1):50-9. PubMed ID: 14694521 [Abstract] [Full Text] [Related]
20. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. Yan J, Yu CT, Ozen M, Ittmann M, Tsai SY, Tsai MJ. Cancer Res; 2006 Nov 15; 66(22):11039-46. PubMed ID: 17108143 [Abstract] [Full Text] [Related] Page: [Next] [New Search]